How to Buy Progyny Stock
Progyny Inc
Progyny, Inc. , a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States.
Progyny stock last closed at $21.37, down 0.33% from the previous day, and has decreased 35.36% in one year. It has overperformed other stocks in the Health Information Services industry by 0.35 percentage points. Progyny stock is currently +59.6% from its 52-week low of $13.39, and -36.85% from its 52-week high of $33.84.
As of Apr 21, 2025, there are 85.41M shares of PGNY outstanding. The market cap of PGNY is $1.83B. In the past 24 hours, 978,655 PGNY shares were traded.
How to Buy Progyny Stock
Wondering how to invest in Progyny stock? Here's how.
- Choose where to buy Progyny stock: You need to decide on an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you decide where to buy Progyny stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Select your payment method and add your info.
- Evaluate Progyny stock: The Progyny ticker symbol is PGNY. Is Progyny stock a good investment? Should you buy shares of PGNY? How do PGNY's underlying business fundamentals look? Do top analysts think Progyny is a good buy? Why has PGNY's stock price moved recently? (Hint: Our stock research website can help you figure out if PGNY is a good stock to buy).
- Execute your PGNY buy order: Decide if you will purchase PGNY shares at the current market price or use a limit order to buy PGNY stock at a given price.
- Get updates on your PGNY investment: Create a watchlist to monitor your investment in Progyny stock.
Step 1: Choose where to buy Progyny stock
You need an online brokerage account in order to access the NASDAQ market and buy PGNY shares.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Technology to Healthcare, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal info so you are able to buy PGNY stock today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open a new trading account.
- Send your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have opened your account on the best stock trading app for beginners, your next step is to transfer the money for your investment:
Watch this video walkthrough if you need help transferring funds into your brokerage account.
Step 4: Evaluate Progyny stock
After you have identified the best place to buy Progyny stock, it's important to research their stock before you invest, so you truly understand the risk and upside.
Progyny shares data
Progyny Overview
WallStreetZen was built to help everyday investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on PGNY's stock page.
How is PGNY stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge PGNY's true value.
Using relative valuations measures:
- PGNY could be overvalued based on its P/E ratio of 36.22x, relative to Health Information Services industry P/E ratio of 10.54x
- PGNY may be overvalued based on its P/B ratio of 4.32x, relative to Health Information Services industry P/B ratio of 3.29x
- PGNY could be overvalued based on its PEG ratio of 1.89x
You can access additional valuation research on PGNY's stock here.
PGNY Financials at a glance
Passed Financial Due Diligence Checks:
- PGNY's operating cash flow of $179.11M allows it to safely service it's debt of $16.41M.
- There are more short-term assets than long-term liabilities on the PGNY balance sheet.
- PGNY earnings of $83.20M is not sufficient to cover its interest payments.
- There are more short-term assets than short-term liabilities on the PGNY balance sheet.
Failed Financial Due Diligence Checks:
- PGNY has a relatively high debt to equity ratio of 0.44.
- Total PGNY debt is higher than 5 years ago, relative to shareholder equity.
- PGNY profit margin has gone down from 5.7% to 4.7% in the past year.
Is it a good time to buy Progyny stock, according to analysts?
Out of 6 Equities analysts who research PGNY, the consensus analyst rating on PGNY is a Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent PGNY Analyst Forecasts
Jailendra Singh, a bottom 2% analyst from Truist Securities downgrades PGNY to a hold rating and lowers their PGNY price target from $26.00 to $19.00, on Nov 13, 2024.
You can dig deeper into what analysts are saying on the Progyny stock forecast page.
PGNY Trading Indicators
PGNY Performance Numbers
Last year, PGNY earnings were $54.34M. Over the last four year, PGNY's earnings have grown by 2.24% per year. This was faster than the Health Information Services industry average of -3.92%.
Last year, PGNY revenue was $1.17B. Over the last 5 year, PGNY's revenue has gone up by 38.42% per year. This was faster than the Health Information Services industry average of 22.41%.
You can analyze PGNY's earnings and revenue performance here.
Latest Insiders Trades at PGNY
In the past 12 months, executives and large shareholders at PGNY have bought more shares than they have sold.
Peter Anevski, CHIEF EXECUTIVE OFFICER of PGNY, was the latest PGNY insider to sell. They sold $178,206.18 worth of PGNY shares on Apr 1, 2025.
Get more info about who owns PGNY stock here.
Can I rely on PGNY as an income stream?
No, Progyny doesn't provide an income stream by paying out dividends.
What do other traders have to say about PGNY?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your PGNY buy order
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually the best for newer investors. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a particular price, use a limit order.
Click the Open Trade button and your broker will place the order.
If you want additional help with buying stocks on eToro, click the how to video below:
Step 6: Get updates on your PGNY investment
Now that you own some shares in PGNY, you'll want to keep up with your shares.
Start a watchlist to monitor your PGNY stock.
PGNY Feed
How to Buy Stock in Progyny
To reiterate, here are the 6 steps you need to take to buy Progyny stock right now:
- Choose where to buy Progyny stock
- Sign up for your brokerage account
- Deposit money your brokerage account
- Evaluate Progyny stock
- Execute your PGNY buy order
- Get updates on your PGNY investment
If you are looking for a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Progyny, add PGNY to your watchlist by clicking the button below.
More "How To" Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.